Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Maximum days to obtain a report for the CD19 Flowcytometry Test: 5 days

What are the prerequisites for the test CD19, Flowcytometry Test

  • There are no specific prerequisites for the CD19 Flowcytometry Test.
  • However, it is recommended to inform the healthcare provider about any medications or supplements being taken.
  • It is also advised to follow any instructions provided by the healthcare provider before the test, such as fasting or avoiding certain medications.

What are the measure values for the test CD19, Flowcytometry Test

Measure Normal Range
CD19 Positive Cells 2-15%
CD19 Mean Fluorescence Intensity 100-500
CD19 Median Fluorescence Intensity 200-800

What does this test CD19, Flowcytometry Test identify?

  • This test identifies the CD19 protein, which is a cell surface marker found on B lymphocytes.
  • Flow cytometry is used to analyze the presence and quantity of CD19 on the surface of cells.
  • Abnormal expression of CD19 can be indicative of certain diseases such as B cell lymphomas or leukemias.
  • Results of the test can help in the diagnosis and monitoring of these conditions.

Why is this test CD19, Flowcytometry Test taken?

  1. CD19 Flowcytometry Test

    The CD19 Flowcytometry Test is performed to analyze the presence of CD19, a protein found on the surface of B cells, in the blood or bone marrow. This test is commonly used in the diagnosis and monitoring of various diseases, including lymphoma, leukemia, and autoimmune disorders.

  2. Reasons for Taking the Test
    • To diagnose B-cell-related cancers such as B-cell lymphoma and leukemia.
    • To monitor the effectiveness of treatment for B-cell malignancies.
    • To evaluate the immune system's response in autoimmune disorders where B cells play a role.
    • To assess the presence of minimal residual disease in patients who have undergone treatment for B-cell malignancies.

No FAQs available.

Customer Google Rating